Brummelhuis, "Preparation of the Prothrombin Complex", Methods of Plasma Protein Fractionation, pp. 117-125 (1980). |
Mannucci, "Outbreak of Hepatitis A Among Italian Patients with Haemophilia", The Lancet, vol. 339, p. 819 (Mar. 28, 1992). |
Pape et al., "Standardization of an in vitro Red Blood Cell Test for Evaluating the Acute Cytotoxic Potential of Tensides", Arzneim.-Forsch./Drug Res. 40, pp. 498-502 (1990). |
Vogelaar et al., "Contributions to the Optimal Use of Human Blood", Vox Sanguinis, vol. 26, (1974). |
Mannucci et al., "Low Risk of Viral Infection After Administration of Vapor-Heated Factor VIII Concentrate", Transfusion, vol. 32, pp. 134-138 (1992). |
Muller, W., "New Ion Exchangers for the Chromatography of Biopolymers", Journal of Chromatography, 510, pp. 133-140 (1990). |
E.F. Vogelaar, "Contributions to the Optimal Use of Human Blood", 1974, vol. 26, pp. 118-127. |
Hellmut Hartert, "Thrombosis and Bleeding Disorders", 1971, pp. 70-76. |
T. Seelich, "Side Effects of Therapy with Clotting Factor Concentrates", 1980, pp. 199-208. |
H. Suomela "Preparation and Properties of a Therapeutic Factor IX Concentrate", 1977, Vox Sanguinis, Journal of Blood Transfusion, Immunohaemotology and Immunopathology, vol. 33, pp. 37-50. |
Ralph Clemens, Wie Virussicher Sind Blut Und Plasmaderivate?, Z. Allg. Med. 65, 429-433 (1989) pp. 429-433. |
Commission of European Communities,"AD HOC Working Party on Biotechnology/Pharmacy" 111/8115/89-EN Final, pp. 1-15, 1989. |
D.B. Rubinstein, M.D., Inability of Solvent-Detergent (S-D) Treated Factor VIII Concentrate to Inactivate Parvoviruses and Non-Lipid Enveloped Non-A, Non-B Hepatitis Virus in Factor VIII Concentrate: Advantages to Using Sterlizing 100 C Dry Heat Treatment. 1990. |
A.M. Prince, The Development of Virus-Free Labile Blood Derivatives. Eui. J.Epidemiol, Jun. pp. 103-118. |
Chemical Abstracts, vol. 111, Nov. 27, 1989, No. 22, 201439j. |
Chemical Abstracts, vol. 114, Feb. 4, 1991, No. 5, 39082a. |
Rozenberg, XII International Congress on Blood Transfusion Abstracts, Aug. 17-23, 1969, Moscow, pp. 473-475. |
"The Inactivation of Viruses," Chap. 3, pp. 63-65. |
Epstein, J.S., et al., "Arch. Pathol. Lab Med.," vol. 114, Mar. 1990, pp. 335-340. |
Levings, R.L., "Veterinary Microbiology." vol. 9, 1984, pp. 313-328. |
Morgenthaler, J.J.(ed.); Curr. Stnd. Hematol. Blood Transfus. Basel, Karger; Virus Inactivation in Plasma Products, No. 56, 1989, pp. 23-33. Heimburger, N., et al. |
Rubinstein, A.I.; et al.; Vox Sang, vol. 60(1), Jan. 1991, p. 60. |
Meng, Z., et al; Applied and Environmental Microbiology, vol. 53(4), Apr. 1987, pp. 727-730. |
Horowitz, B., et al; Transfusion, vol. 25(6), Nov.-Dec. 1985, pp. 516-522. |
Piet, M.P.J, et al.; Transfusion, vol. 30(6), Jul./Aug. 1990, pp. 591-598. |
Piszkiewicz, D., et al; Thrombosis Research, vol. 55(5), Sep. 1, 1989, pp. 627-634. |
Chemical Abstracts, vol. 84, No. 16, Apr. 19, 1976, US Abstract No. 111640n Dec. 25, 1975. |